Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fritze

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Der Nervenarzt|February 13, 2009
[Position of the German Society of Psychiatry, Psychotherapy and Neurology (DGPPN) on the "Recommendations of the Drug Commission of Germany on the medical control of benzodiazepine-like hypnotics"]G Gründer, J Aldenhoff, F Bergmann, et al.
Psychopharmacology|January 1, 1989
Plasma moclobemide and metabolites: lack of correlation with clinical response and biogenic aminesJ Fritze, G Laux, E Sofic, et al.
Neuroscience|January 1, 1989
Demonstration of monoamine oxidase-A and -B in the human brainstem by a histochemical techniqueC Konradi, J Kornhuber, L Froelich, et al.
MMW Fortschritte Der Medizin|February 25, 2005
[Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?]H J Möller, M Bauer, J Fritze, et al.
Biological Psychiatry|June 1, 1989
Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humansK P Lesch, R Rupprecht, B Poten, et al.
Pharmacopsychiatry|October 30, 1999
Competence to give informed consent to clinical studies. Statement by the taskforce on "ethical and legal questions" of the Association for Neuropsychopharmacology and Pharmacopsychiatry ("Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie [AGNP]")N Nedopil, J Aldenhoff, K Amelung, et al.
Pharmacopsychiatry|August 27, 1999
[Opinion of the "Ethical and Just Questions" work group for neuropsychopharmacology and pharmacopsychiatry (AGNP)]N Nedopil, J Aldenhoff, K Amelung, et al.
American Journal of Human Genetics|April 1, 1993
Pseudoautosomal marker DXYS20 and manic depressionM M Nöthen, S Cichon, J Erdmann, et al.
Molecular Psychiatry|March 10, 1998
Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of diseaseJ Deckert, M M Nöthen, P Franke, et al.
The American Journal of Psychiatry|February 1, 1992
Lack of association between dopamine D1 and D2 receptor genes and bipolar affective disorderM M Nöthen, J Erdmann, J Körner, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Der Nervenarzt|February 13, 2009
[Position of the German Society of Psychiatry, Psychotherapy and Neurology (DGPPN) on the "Recommendations of the Drug Commission of Germany on the medical control of benzodiazepine-like hypnotics"]G Gründer, J Aldenhoff, F Bergmann, et al.
Psychopharmacology|January 1, 1989
Plasma moclobemide and metabolites: lack of correlation with clinical response and biogenic aminesJ Fritze, G Laux, E Sofic, et al.
Neuroscience|January 1, 1989
Demonstration of monoamine oxidase-A and -B in the human brainstem by a histochemical techniqueC Konradi, J Kornhuber, L Froelich, et al.
MMW Fortschritte Der Medizin|February 25, 2005
[Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?]H J Möller, M Bauer, J Fritze, et al.
Biological Psychiatry|June 1, 1989
Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humansK P Lesch, R Rupprecht, B Poten, et al.
Pharmacopsychiatry|October 30, 1999
Competence to give informed consent to clinical studies. Statement by the taskforce on "ethical and legal questions" of the Association for Neuropsychopharmacology and Pharmacopsychiatry ("Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie [AGNP]")N Nedopil, J Aldenhoff, K Amelung, et al.
Pharmacopsychiatry|August 27, 1999
[Opinion of the "Ethical and Just Questions" work group for neuropsychopharmacology and pharmacopsychiatry (AGNP)]N Nedopil, J Aldenhoff, K Amelung, et al.
American Journal of Human Genetics|April 1, 1993
Pseudoautosomal marker DXYS20 and manic depressionM M Nöthen, S Cichon, J Erdmann, et al.
Molecular Psychiatry|March 10, 1998
Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of diseaseJ Deckert, M M Nöthen, P Franke, et al.
The American Journal of Psychiatry|February 1, 1992
Lack of association between dopamine D1 and D2 receptor genes and bipolar affective disorderM M Nöthen, J Erdmann, J Körner, et al.
Pageof 14